Properties and specificities of sphingosine kinase from blood platelets.
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001792:Blood Platelets / Q000187:drug effects / Q000201:enzymology*; D002458:Cell Fractionation; D002462:Cell Membrane / Q000201:enzymology; D002855:Chromatography, Thin Layer; D003593:Cytoplasm / Q000201:enzymology; D003594:Cytoplasmic Granules / Q000201:enzymology; D003597:Cytosine Nucleotides / Q000494:pharmacology; D004355:Drug Stability; D004492:Edetic Acid / Q000494:pharmacology; D005615:Freezing; D006160:Guanosine Triphosphate / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008274:Magnesium / Q000494:pharmacology; D008345:Manganese / Q000494:pharmacology; D010770:Phosphotransferases / Q000097:blood*; D013045:Species Specificity; D013110:Sphingosine; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D013552:Swine; D014316:Tritium; D014500:Uracil Nucleotides / Q000494:pharmacology
D003597:Cytosine Nucleotides; D014500:Uracil Nucleotides; D014316:Tritium; D008345:Manganese; D006160:Guanosine Triphosphate; D000255:Adenosine Triphosphate; D004492:Edetic Acid; D010770:Phosphotransferases; D008274:Magnesium; D013110:Sphingosine